GLP Dex started as a reference — a place to understand what these drugs actually do before talking to a doctor. That part is the series of posts in this collection: the receptor breakdown, the drug families, the trial data.
But the information problem is only half of it. The access problem is the other half. Someone reads the retatrutide profile, understands they're a candidate for a GLP-1 drug, and then... calls around to clinics that have no web presence, gets routed to a telehealth platform optimized for conversion not care, or pays out of pocket to a med spa that emails them a PDF protocol.
The platform layer is what closes that gap.
What we're building
Three connected surfaces, one network.
The clinic side — dashboard and storefront
Clinics that offer GLP-1 treatment sign up and get two things:
A storefront — their public-facing page on GLP Dex. Not a scraped listing, not a Yelp card. An actual branded page they control: which drugs they offer, their protocols, their pricing, their providers. The educational content from GLP Dex surfaces contextually — if a clinic offers tirzepatide, the tirzepatide drug profile and comparison data lives alongside their listing. They get a professional web presence without building one.
A dashboard — the backend for managing their patients. Intake and screening workflows, dosing titration tracking, messaging, lab result uploads, refill approvals. Everything a weight loss or GLP-1 clinic needs to run their patient side, built specifically for this context rather than adapted from a generic EMR.
The directory is built from clinics that actually join — not scraped from Google Maps or Zocdoc. That means every listing is a real relationship, the data is accurate, and clinics have a reason to keep their information current because it's their storefront, not a listing they don't control.
The patient side — tracking and connection
Patients get a dashboard that tracks their treatment over time:
- Current drug, dose, and titration stage
- Next injection or dose date
- Weight and symptom log
- Messaging with their clinic
- Lab results when their provider uploads them
- Educational content from GLP Dex surfaced at the right moment — you're starting week 4 of tirzepatide, here's what side effects are typical at this stage and when they usually resolve
The clinic connection is the core. A patient is tied to their provider the way you're tied to your primary care doctor — the history, the notes, the dosing decisions all live in that relationship. But if a patient wants to switch clinics — better pricing, moved cities, different drug protocol — they can. Their data moves with them. The platform isn't a lock-in mechanism for the clinic, it's a portable record for the patient.
The network effect
The reason to build a custom directory rather than aggregate existing listings: scraped data is a commodity. Any competitor can scrape the same sources. A network of clinics that chose to be here, that have active dashboards and real patient relationships on the platform, is defensible. Each clinic that joins makes the directory more useful for patients. Each patient that joins gives clinics a reason to be active.
The GLP Dex content is the top of the funnel — someone searching for drug information lands here, reads the profiles, understands their options, finds a clinic. That content moat feeds the network.
What this is not
Not a telehealth platform doing its own prescribing. Not a pharmacy. Not a subscription weight loss program with a coaching layer.
The infrastructure layer for GLP-1 care — connecting the patient who knows what they want to the clinic that can provide it, and giving both of them tools to manage the relationship well.
The drugs are complicated. The access shouldn't be.